Sumner Michael John 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Award
Common Stock Option
[F1]2026-03-04+36,832→ 36,832 totalExercise: $1.73Exp: 2036-02-26→ Common Stock (36,832 underlying) - Award
Restricted Stock Unit
[F2]2026-03-04+29,608→ 29,608 total→ Common Stock (29,608 underlying)
Footnotes (2)
- [F1]The vesting schedule for the 36,832 options granted on March 4, 2026 was as follows: 12,278 shares will vest on February 26, 2027; 12,277 shares will vest on February 26, 2028; 12,277 shares will vest on February 26, 2029.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870 shares will vest on February 26, 2027; 9,869 shares will vest on February 26, 2028; and 9,869 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Signature
/s/ Michael John Sumner|2026-03-05